The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3
Open accessAbstract
Spinocerebellar ataxia type 3 is a neurodegenerative disorder caused by the expansion of the polyglutamine repeat region within the ataxin-3 protein. The mutant protein forms intracellular aggregates in the brain. However, the cellular mechanisms causing toxicity are still poorly understood and there are currently no effective treatments. In this study we show that administration of a rapamycin ester (cell cycle inhibitor-779, temsirolimus) improves motor performance in a transgenic mouse model of spinocerebellar ataxia type 3. Temsirolimus inhibits mammalian target of rapamycin and hence upregulates protein degradation by autophagy. Temsirolimus reduces the number of aggregates seen in the brains of transgenic mice and decreases levels of cytosolic soluble mutant ataxin-3, while endogenous wild-type protein levels remain unaffected. Temsirolimus is designed for long-term use in patients and therefore represents a possible therapeutic strategy for the treatment of spinocerebellar ataxia type 3. Using this disease model and treatment paradigm, we employed a microarray approach to investigate transcriptional changes that might be important in the pathogenesis of spinocerebellar ataxia type 3. This identified ubiquitin specific peptidase-15, which showed expression changes at both the messenger ribonucleic acid and protein level. Ubiquitin specific peptidase-15 levels were also changed in mice expressing another mutant polyglutamine protein, huntingtin. In total we identified 16 transcripts that were decreased in transgenic ataxin-3 mice that were normalized following temsirolimus treatment. In this mouse model with relatively mild disease progression, the number of transcripts changed was low and the magnitude of these changes was small. However, the importance of these transcriptional alterations in the pathogenesis of spinocerebellar ataxia type 3 remains unclear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Self-citationThe roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
Self-citationTor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast
Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,309
HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234
Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
Ravikumar, B. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1107 · Cited by 1,111
Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis
Schöls, L., Bauer, P., Schmidt, T., Schulte, T., & Riess, O. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00737-9 · Cited by 1,058
Self-citationLithium induces autophagy by inhibiting inositol monophosphatase
Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L. J., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504035 · Cited by 985
Self-citationRecruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E. K., Saiki, S., Siddiqi, F. H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.79 · Cited by 800
Self-citationSchilling, G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.397 · Cited by 753
Rapamycin alleviates toxicity of different aggregate-prone proteins
Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., Pangalos, M. N., Schmitt, I., Wullner, U., Evert, B. O., O'Kane, C. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi458 · Cited by 657
Self-citationLithium delays progression of amyotrophic lateral sclerosis
Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708022105 · Cited by 550
Transcriptional abnormalities in Huntington disease
Sugars, K. L., & Rubinsztein, D. C. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00074-x · Cited by 529
Self-citationRegulation of intracellular accumulation of mutant Huntingtin by Beclin 1
Shibata, M., Lu, T., Furuya, T., Degterev, A., Mizushima, N., Yoshimori, T., MacDonald, M., Yankner, B., & Yuan, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600364200 · Cited by 458
Huntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
Self-citationRapamycin pre-treatment protects against apoptosis
Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C. J., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl036 · Cited by 403
Self-citationBurnett, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg344 · Cited by 373
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C. J., & Rubinsztein, D. C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm294 · Cited by 349
Self-citationRNA toxicity is a component of ataxin-3 degeneration in Drosophila
Li, L.-B., Yu, Z., Teng, X., & Bonini, N. M. (2008) · Nature · doi:10.1038/nature06909 · Cited by 316
Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation
Perez, M. K., Paulson, H. L., Pendse, S. J., Saionz, S. J., Bonini, N. M., & Pittman, R. N. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.6.1457 · Cited by 314
Warrick, J. M., Morabito, L. M., Bilen, J., Gordesky-Gold, B., Faust, L. Z., Paulson, H. L., & Bonini, N. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.030 · Cited by 267
Recovery from Polyglutamine-Induced Neurodegeneration in Conditional SCA1 Transgenic Mice
Zu, T., Duvick, L. A., Kaytor, M. D., Berlinger, M. S., Zoghbi, H. Y., Clark, H. B., & Orr, H. T. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2978-04.2004 · Cited by 262
Doss-Pepe, E. W., Stenroos, E. S., Johnson, W. G., & Madura, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6469-6483.2003 · Cited by 237
Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities
Li, F., Macfarlan, T., Pittman, R. N., & Chakravarti, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205259200 · Cited by 213
Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates
Zhong, X., & Pittman, R. N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl164 · Cited by 200
Bichelmeier, U., Schmidt, T., Hübener, J., Boy, J., Rüttiger, L., Häbig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W. J., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-06.2007 · Cited by 195
Self-citationRegulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3
Wang, Q., Li, L., & Ye, Y. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605100 · Cited by 179
Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3
Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.289 · Cited by 171
Chai, Y., Berke, S. S., Cohen, R. E., & Paulson, H. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310939200 · Cited by 169
Evert, B. O., Araujo, J., Vieira-Saecker, A. M., de Vos, R. A. I., Harendza, S., Klockgether, T., & Wüllner, U. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2053-06.2006 · Cited by 162
Vacher, C., Garcia-Oroz, L., & Rubinsztein, D. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi372 · Cited by 160
Self-citationElucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics
Scheel, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg297 · Cited by 159
A molecular investigation of true dominance in Huntington’s disease
Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. A., & Rubinsztein, D. C. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.10.739 · Cited by 158
Self-citationHetfeld, B. K. J., Helfrich, A., Kapelari, B., Scheel, H., Hofmann, K., Guterman, A., Glickman, M. H., Schade, R., Kloetzel, P., & Dubiel, W. (2005) · Current Biology · doi:10.1016/j.cub.2005.05.059 · Cited by 153
Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzlePreprint
Riley, B. E., & Orr, H. T. (2006) · Genes & Development · doi:10.1101/gad.1436506 · Cited by 151
Structural and functional analysis of ataxin‐2 and ataxin‐3
Albrecht, M., Golatta, M., Wüllner, U., & Lengauer, T. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04245.x · Cited by 145
Mechanisms of resistance to rapamycins
Huang, S., & Houghton, P. J. (2001) · Drug Resistance Updates · doi:10.1054/drup.2002.0227 · Cited by 143
King, M. A., Hands, S., Hafiz, F., Mizushima, N., Tolkovsky, A. M., & Wyttenbach, A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043398 · Cited by 120
Josephin domain of ataxin‐3 contains two distinct ubiquitin‐binding sites
Nicastro, G., Masino, L., Esposito, V., Menon, R. P., Simone, A. D., Fraternali, F., & Pastore, A. (2009) · Biopolymers · doi:10.1002/bip.21210 · Cited by 79
Study of subcellular localization and proteolysis of ataxin-3
Pozzi, C., Valtorta, M., Tedeschi, G., Galbusera, E., Pastori, V., Bigi, A., Nonnis, S., Grassi, E., & Fusi, P. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.011 · Cited by 56
Cited by
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
Settembre, C., Fraldi, A., Medina, D. L., & Ballabio, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3565 · Cited by 1,697
The Biology of Proteostasis in Aging and Disease
Labbadia, J., & Morimoto, R. I. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033955 · Cited by 1,472
Autophagy modulation as a potential therapeutic target for diverse diseases
Rubinsztein, D. C., Codogno, P., & Levine, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3802 · Cited by 1,437
Self-citationAutophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
Self-citation
Metadata
- Authors
- Menzies, F. M., Huebener, J., Renna, M., Bonin, M., Riess, O., & Rubinsztein, D. C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-09
- Volume
- 133
- Issue
- 1
- Pages
- 93-104
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2004219186
- Cited by
- 262
- References
- 42
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.